Clinical Trial Update: Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lixisenatide versus placebo as add-on therapy to basal insulin and/or oral antidiabetic treatment in older adults with Type 2 diabetes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Adlyxin (lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2016-10-14